Clinical Associate Professor, Radiology
Area of Interest
I am a nuclear medicine radiologist who has been reading oncology studies (PET, bone scan, and MIBG) for eight years. I have participated in a number of research studies, including assessing the size of detectable brain metastases from melanoma, assessing the prognostic value of FDG-PET for response post-chemoradiotherapy and using C11-AMT to predict response to pembrolizumab. I am presently interested in validating new techniques and assisting with the imaging components of clinical trials.